Biotech Firm Amorphical Reports Breakthrough in Crohn’s Disease Therapy
Israeli biotech Amorphical announces breakthrough Crohn’s therapy, achieving sustained remission with nano-amorphous Calcium Carbonate in Phase 2 trial at.
















Real-time breaking news coverage from Israel and the Middle East. Stay informed with the latest developments as they happen.
Israeli biotech Amorphical announces breakthrough Crohn’s therapy, achieving sustained remission with nano-amorphous Calcium Carbonate in Phase 2 trial at.